AMAbirlal Mukherjee

Abirlal Mukherjee

*This is an algorithmically generated author record based on publicly available information.

Abirlal Mukherjee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • IITRS: A Promiscuous Enzyme Synchronizing β-Lactamase with Esterase

    by Abirlal Mukherjee, Jyoti Barman, Rajsekhar Adhikary, Kunal Dhankhar, Sourya Bhattacharya, Niteesh Kumar Pandey, Ayushi Singh, Saugata Hazra

    This study reveals dual catalytic activities (β-lactamase and esterase) in a new penicillin-recognizing protein (IITRS), found in two closely related species, Enterococcus faecium and Enterococcus lactis. IITRS is distinct from other β-lactamase classes, showing only limited structural and functional similarity to class C β-lactamases. The conserved KTG motif, which helps in substrate recognition in class C, is not present in this enzyme. The enzyme is different from class C in terms of different conserved loops, such as R2 and Ω loops, which are involved in the recognition, specificity, and hydrolysis of β-lactams. Nevertheless, the involvement of Ser64 and Tyr150 residues in β-lactam hydrolysis as found in class C enzymes has been demonstrated by site-directed mutagenesis. The study also highlights Tyr150 from the catalytic triad Tyr-Asp-Lys as being responsible for the esterase activity. This dual functionality confers catalytic promiscuity, enabling IITRS to function through two different mechanisms. The enzyme exhibits hydrolysis of p-NP esters (acetate, butyrate, hexanoate, decanoate, and laurate) displaying progressively higher activity with increasing alkyl chain lengths. Since Tyr150 has been found as a common ligand-binding residue for both of the activities, the β-lactamase inhibition by diisopropyl fluorophosphate (DFP), a reported inhibitor of bacterial esterase, also has been demonstrated. This promising albeit unexplored biocatalyst also might be used in the production of chiral compounds, investigating its enantioselective nature similar to other bacterial esterases. Overall, this research upholds a new promiscuous enzyme and proposes a distinct active site, narrower than that of a β-lactamase and wider than that of an esterase.

  • AHM-1: An Inclusion to the Arsenal of β-Lactam Resistance in Clostridioides difficile

    by Abirlal Mukherjee, Jyoti Barman, Chandrachur Ghosh, Rajsekhar Adhikary, Kunal Dhankhar, Partha Roy, Sulagna Basu, Saugata Hazra

    This study delves into a newly discovered MBL (metallo-β-lactamase) in Clostridioides difficile, a formidable pathogen known for causing nosocomial infections and exhibiting resistance to antimicrobial agents. The primary objective was to unravel its structure-function relationship. This research establishes the enzyme AHM-1 as a subclass B3-like MBL. Experimental results reveal that the enzyme's active site consists of two Zn2+ atoms exhibiting tetrahedral and trigonal bipyramidal coordination, similar to B1 and B3 MBLs. Notably, within its active site, it exhibits a lower binding capacity for other transition metal ions such as Fe2+, Mn2+, and Ni2+ compared to Zn2+. The zinc-binding sites of B1 and B3 MBLs contain strictly conserved His116-His118-His196 and Asp120-Cys221/His121-His263. The absence of all the conserved residues except His116, Asp120, and His121 in the Zn-binding site distinctly separates this enzyme from these two MBL subclasses. Conserved zinc binding motifs present in B1 and B3 MBLs are H-X-H-X-D and H-X-H-X-D-H, respectively. The presence of the H-X-D-X-D-H motif in the enzyme, similar to that in B3 enzymes, along with sequence and structural analysis, places this new enzyme closer to the enzymes belonging to the B3 subclass. This study also identifies the likely catalytic residues responsible for its β-lactamase activity, similar to B3 MBLs. In contrast to MBLs, this enzyme displays hydrolytic activity toward aztreonam. It also shows higher catalytic efficiency toward higher generation cephalosporins. This study thus underscores the significance of a novel enzyme with β-lactamase activity in Clostridioides difficile, highlighting its potential implications for clinical treatment due to its disparities from conventional MBLs.